You have successfully logged out.

Hello !
Logout

Reducing Underdosing

Underdosage 

a cause of medication errors

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professional before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.
underdosage graphic

In small volume infusions up to 32.2% of active agent remain in IV line3

Products that can help minimising medication errors

Intrafix® SafeSet

Gravity sets (G) are IV administration sets for gravity infusion.Pressure set (P) are IV administration sets for gravity and pressure infusions with compatible (non-dedicated) infusion pumps (pressure resistant up to 2 bar acc. to ISO 8536-8)

Infusomat® Space® Line PVC

Infusomat® Space® Line Basic PVC are dedicated IV lines for the administration of standard infusions in combination with B. Braun Infusomat® Space®, Infusomat® Spaceplus and Infusomat® fmS.The line consists of PVC (not manufactured with DEHP) and a silicon pump segment and is available in various lengths.

Cyto-Set® Infusomat® Space

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow. Cyto-Set® Infusomat® SpaceIV administration set for the application of cytostatics. For infusion by compatible pumps.Connection set for the administration of cytostatic drugs by compatible pumps. Cyto-Set® Infusomat® Space is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusomat® Space to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Cyto-Set® Mix, Cyto-Set® Line

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system.The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® MixConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.The Cyto-Set® Mix allows to connect a normal infusion container with a solution dedicated for cytotoxic drugs (NaCl 0,9% or Glucose 5%) to vent the line. The drug is put in the container via a needle-free injection valve. So the line of the Cyto-Set® Mix leading to Cyto-Set® Infusion, Cyto-Set® Infusomat® Space or Cyto-Set® Infusomat® plus is free of cytotoxic drugs.Cyto-Set® LineConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.Cyto-Set® Line connects primed solutions. This component consists of only one spike and a polyurethane transition tube, clamp and a fill-stop-cap (Prime Stop).Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Dosifix® SafeSet

In gravity infusion, Dosifix® SafeSet allows a precise dosage of solution which is given to the patient. This functionality is particularly important for neonatal, pediatric and geriatric care. In gravity or pump-controlled* flow-situations Dosifix® SafeSet is also used for an intermittent infusion of medication in its correct dilution in a closed system with the ability to flush the IV line after each application for mono and multiple therapy without the need to re-spike.

(last access June 2021)

 

[1] Toh, M. R., Teo, V., Kwan, Y. H., Raaj, S., Tan, S. Y., & Tan, J. Z. (2014). Association between number of doses per day, number of medications and patient’s non-compliance, and frequency of readmissions in a multi-ethnic Asian population. Preventive Medicine Reports, 1, 43-471. This study investigated whether the number of doses per day and the number of medications are significantly associated with the number of readmissions.

[2] Hughes, R. G. (Ed.). (2008). Patient safety and quality: An evidence-based handbook for nurses. Rockville, MD: Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services.

[3] Plagge, H., Golmick, J., Bornand, D., & Deuster, S. (2010). Evaluation of the dead volume in intravenous short-term infusion. EJHP Science, 16, 31-37.

[4] NHS England. (2015). Are you under infusing IV antibiotic infusions? Sign up to Safety Webinar https://www.england.nhs.uk/signuptosafety/wp-content/uploads/sites/16/2015/11/su2s-infusing-iv-antibiotics-webinar.pdf

[5]. Cousins, D. (2018). Patients are being underdosed: we need new guidance on small-volume drug infusions. Clinical Pharmacist, 10(12), 356-357.

[6] J.K. Aronson, Medication errors: what they are, how they happen, and how to avoid them, QJM: An International Journal of Medicine, Volume 102, Issue 8, August 2009, Pages 513–521, https://doi.org/10.1093/qjmed/hcp052

[7] Cooper, D.M., Rassam, T., & Mellor, A. (2018). Non-flushing of IV administration sets: an under-recognised under-dosing risk. British Journal of Nursing, 27(14)

[8] Gregerson, B.G., Harrison, S.K., Garrett, J.S., Kohman, K.N., & Kline, J.A. (2018). Comparison of outcomes in patients with intracranial hemorrhage on factor Xa inhibitors versus vitamin K antagonists treated with 4-factor prothrombin complex concentrate. Proceedings (Baylor University Medical Center), 31(2), 153-156.

[9] Chan, Y. K., Chan, A. H., & Wong, A. K. (2013). A novel approach for the detection of atrial fibrillation in single lead ECG using statistical features and random forest. CMBES Proceedings, 36(1), 1–4. 1.

[10] Cousins, D. (2018). Patients are being underdosed: we need new guidance on small-volume drug infusions. Clinical Pharmacist, 10(12), 356–357.

[11] Hidden Medication Loss When Using a Primary Administration Set for Small-Volume Intermittent Infusions.” Institute For Safe Medication Practices. December 3, 2020 https://www.ismp.org/resources/hidden-medication-loss-when-using-primary-administration-set-small-volume-intermittent

[12] MacLachlan L et al, Antimicrobial Stewardship – Ensuring full prescribed Dose Delivery of IV Antibiotics in OPAT, Hull University Teaching Hospitals, NHS Trust

[13] Fish, D., & Ohlinger, M. (2006). Antibiotic resistance among bacteria: One of the world’s most serious health problems. In “Molecular characterization of multidrug-resistant avian pathogenic Escherichia coli isolated from poultry and poultry products” by Deshmukh, O., Suryawanshi, R., Kurkure, N., Kaore, M., Badar, S., Shinde, O., Awandkar, S., & Gaikwad, N. Indian Journal of Animal Sciences, 93(5), 431–436

[14] Centers for Disease Control and Prevention. (2019). Antibiotic Resistance Threats in the United States, 2019 retrived from CDC 2015, https://www.cdc.gov/drugresistance/biggest-threats.html

[15] Gurney, H. (2002). How to calculate the dose of chemotherapy. British Journal of Cancer, 86(8), 1297-1302.

[16] Bowman, S., Raghavan, K., & Walker, I.A. (2013). Residual anaesthesia drugs in intravenous lines—a silent threat? Anaesthesia, 68(6), 557-561.

[17] Cooper, D.M., Rassam, T., & Mellor, A. (2018). Non-flushing of IV administration sets: an under-recognised under-dosing risk. British Journal of Nursing, 27(14).

[18] Institute For Safe Medication Practices. (2021). Additional Strategies to Improve Complete Delivery of Small-Volume Intermittent Infusions. Retrieved from https://www.ismp.org/resources/additional-strategies-improve-complete-delivery-small-volume-intermittent-infusions

[19] Peyko, V., An unrecognized Problem in Optimizing Antimicrobial Therapy: Significant Residual Volume Remaining in Intravenous Tubing With Extended-Infusion Piperacillin-Tazobactam, 2021 Journal of Pharmacy Practice Vol. 0.0 1-4.

[20] National Infusion and Vascular Access Society (NIVAS). (2019). Intravenous Infusion Drug Administration: Flushing Guidance. Retrieved from NIVAS-Flushing-gudiance-2019-final.pdf